サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1577508

心臓発作診断の世界市場

Heart Attack Diagnostics

出版日
ページ情報
英文 179 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.76円
心臓発作診断の世界市場
出版日: 2024年10月25日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 179 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

心臓発作診断の世界市場は2030年までに198億米ドルに到達

2023年に137億米ドルと推定される心臓発作診断の世界市場は、分析期間2023-2030年にCAGR 5.5%で成長し、2030年には198億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである病院エンドユーズは、CAGR 6.1％を記録し、分析期間終了までに98億米ドルに達すると予測されます。診断センター・エンドユーズ分野の成長率は、分析期間中CAGR 5.1%と推定されます。

米国市場は37億米ドル、中国はCAGR 9.0％で成長すると予測

米国の心臓発作診断市場は2023年に37億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに42億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは9.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.2%と5.6%と予測されています。欧州では、ドイツがCAGR 3.4%で成長すると予測されています。

世界の心臓発作診断市場- 主要動向と促進要因のまとめ

心臓発作診断が心血管治療のゲームチェンジャーとなる理由とは？

心臓発作診断は、患者の転帰を大きく変える心筋梗塞（MI）を早期かつ正確に検出するための重要なツールを提供し、現代の心血管治療の要となっています。しかし、これらの診断がこれほどまでにインパクトのあるものである理由、そしてヘルスケアにおいてその役割がますます不可欠になってきている理由は一体何なのだろうか？心臓発作は、閉塞によって心臓への血流が制限され、組織の損傷が引き起こされることによって起こる。血栓溶解療法や経皮的冠動脈インターベンション（PCI）のような救命処置の有効性は早期発見にかかっているため、タイムリーな診断は極めて重要です。ゴールデンタイム"-症状発現直後の重要な時間枠-という概念から、臨床医が治療決定の指針となる信頼性の高い迅速な診断ツールを利用できることが不可欠です。現在の診断アプローチは、心電図（ECG）、心臓バイオマーカー検査、画像診断技術を組み合わせて心臓障害の有無と重症度を同定するものです。これらのツールの速度と精度は、患者が適切な治療を時間内に受けられるかどうかを決定する鍵となるため、心臓発作診断における継続的な技術革新の必要性が強調されています。この継続的な進化は、生存率を向上させるだけでなく、長期的な合併症を最小限に抑えることができるため、これらの技術は救急医療と日常診療の両方に不可欠なものとなっています。

心臓発作診断市場を形成している新たな動向は？

心臓発作診断市場は、患者の転帰を改善することを目的とした最先端のイノベーションと臨床実践のシフトによって、変革期を迎えています。最も重要な発展の一つは、高感度心筋トロポニン（hs-cTn）アッセイの採用が拡大していることです。この感度の向上により、心臓発作をより早期かつ正確に発見することが可能となり、特に非典型的な症状を有する患者において、治療までの時間を短縮し、予後予測精度を向上させることができます。もう一つの大きな動向は、POCT（ポイント・オブ・ケア検査）機器の普及です。POCT機器は、ベッドサイドで、あるいは救急車のような病院前の環境でも迅速な診断を可能にします。これらのポータブル機器は、数分で結果を提供することで、より迅速なトリアージをサポートし、集中検査室での検査への依存を減らすことで、救急医療に変革をもたらしつつあります。さらに、診断プラットフォームにおける人工知能（AI）と機械学習の統合は、心電図パターンや画像診断結果などの複雑なデータの解釈に革命をもたらし、人間の臨床医が見過ごす可能性のある微妙な徴候の早期発見につながります。さらに、ナトリウム利尿ペプチドや炎症マーカーなど、複数のバイオマーカーを組み合わせたマルチマーカーパネルは、心臓の健康状態をよりニュアンス豊かに捉え、心臓発作と他の心臓疾患の鑑別に役立つとして注目を集めています。これらの動向を総合すると、心臓発作診断はより速く、より正確に、そしてますます個別化され、心血管治療における精密医療へのシフトを反映しています。

新しいテクノロジーは心臓発作診断をどのように再定義しているのでしょうか？

技術の飛躍的進歩は、心臓発作診断の状況を再形成し、ツールをこれまで以上に効率的で、アクセスしやすく、正確なものにしています。最もインパクトのある進歩の一つは、診断機器の小型化であり、遠隔地や資源が限られた環境であっても、患者のそばで迅速に検査結果を提供できるポータブル・ハンドヘルド・システムの誕生につながっています。ポイント・オブ・ケア心臓バイオマーカー分析装置やポータブル心電図モニターを含むこれらの装置は、複雑な検査室設定を必要とせずに即時診断と治療方針の決定を可能にすることで、救急医療に変革をもたらしつつあります。ウェアラブル・テクノロジーは、この分野におけるもうひとつの変革であり、スマートウォッチやヘルスバンドは現在、心臓活動を継続的にモニターし、ユーザーや医療提供者に心臓発作の可能性のある症状をリアルタイムで警告する機能を備えています。この機能は、潜在的な心臓イベントに対する積極的な管理と迅速な対応を可能にするため、リスクの高い患者にとって特に価値があります。さらに、人工知能（AI）は、複雑な心臓データを迅速かつ正確に解釈できるようにすることで、心エコー図、CTスキャン、MRIなどの画像診断の能力を高めています。AI主導のプラットフォームは、人間の目では見逃されかねない微妙なパターンや異常を検出することができ、より早く、より確実な診断につながっています。さらに、クラウドベースのプラットフォームと遠隔医療統合により遠隔診断が可能になり、臨床医は事実上どこからでも検査結果にアクセスし、解釈することが容易になった。これらの技術革新は、心臓発作診断の精度とアクセシビリティを向上させるだけでなく、心血管治療の提供方法にも革命をもたらし、患者管理に対するより積極的でデータ主導型のアプローチへの道を開いています。

心臓発作診断市場急成長の主な促進要因は？

心臓発作診断市場の成長は、主に技術の進歩、心血管疾患の負担増、迅速でアクセスしやすい診断ソリューションへのシフトなど、さまざまな要因によって後押しされています。主な成長要因の1つは心血管系疾患の世界の増加であり、心血管系疾患は依然として世界の死因のトップです。人口の高齢化は、肥満、高血圧、糖尿病などの生活習慣に関連する危険因子の有病率の増加と相まって、信頼性の高い診断ツールを必要とする患者層を大幅に拡大しています。さらに、早期発見と予防の重要性に対する意識の高まりが、心臓発作を初期段階で特定できる高度なバイオマーカーアッセイや非侵襲的イメージング技術に対する需要を押し上げています。もう1つの主要な促進要因は、ポイントオブケア検査（POCT）機器の採用が拡大していることです。POCT機器は、救急環境、外来診療所、さらには在宅医療環境において迅速な診断機能を提供します。これらのポータブル機器は、迅速な診断と治療開始のニーズに応え、病院の検査室への負担を軽減し、多忙な救急部門における患者の処理能力を向上させています。AIを活用した診断プラットフォームや高感度バイオマーカー検査などの技術革新は、診断精度の向上や個別化リスク評価の実現により、市場の成長をさらに後押ししています。さらに、遠隔医療や遠隔モニタリングソリューションの利用が増加しており、特に従来のヘルスケア施設へのアクセスが制限されている農村部や十分なサービスを受けていない地域において、心臓発作診断の利用範囲が拡大しています。有利な規制の枠組みや償還政策も、新しい診断技術の開発や採用を促し、より幅広い患者層へのアクセスを可能にしています。これらの要因が研究開発への継続的な投資と相まって、市場情勢を前進させ、進化する循環器治療の重要な構成要素としての地位を確立しつつあります。

調査対象企業の例（合計 35注目）

  • Abbott Laboratories, Inc.
  • ACS Diagnostics
  • Baxter International, Inc.
  • Beckman Coulter, Inc.
  • Canon Medical Systems USA, Inc.
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • HeartBeam
  • Midmark Corporation
  • Philips Healthcare

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP24302

Global Heart Attack Diagnostics Market to Reach US$19.8 Billion by 2030

The global market for Heart Attack Diagnostics estimated at US$13.7 Billion in the year 2023, is expected to reach US$19.8 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$9.8 Billion by the end of the analysis period. Growth in the Diagnostic Centers End-Use segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.7 Billion While China is Forecast to Grow at 9.0% CAGR

The Heart Attack Diagnostics market in the U.S. is estimated at US$3.7 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$4.2 Billion by the year 2030 trailing a CAGR of 9.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 5.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Heart Attack Diagnostics Market - Key Trends and Drivers Summarized

Why Are Heart Attack Diagnostics a Game-Changer in Cardiovascular Care?

Heart attack diagnostics have become a cornerstone of modern cardiovascular care, offering critical tools for the early and precise detection of myocardial infarction (MI), which can significantly alter patient outcomes. But what exactly makes these diagnostics so impactful, and why is their role in healthcare becoming increasingly indispensable? Heart attacks occur when a blockage restricts blood flow to the heart, causing tissue damage that, if not treated promptly, can lead to irreversible damage or death. Timely diagnosis is crucial because the effectiveness of life-saving interventions like thrombolysis and percutaneous coronary intervention (PCI) hinges on early detection. The concept of the “golden hour”—the critical time window immediately following the onset of symptoms—makes it imperative that clinicians have access to reliable and rapid diagnostic tools to guide treatment decisions. Current diagnostic approaches rely on a combination of electrocardiograms (ECGs), cardiac biomarker testing, and imaging techniques to identify the presence and severity of heart damage. The speed and accuracy of these tools are key in determining whether a patient receives appropriate care in time, highlighting the need for continuous innovation in heart attack diagnostics. This ongoing evolution not only improves survival rates but also minimizes long-term complications, making these technologies vital for both emergency and routine clinical practice.

Which Emerging Trends Are Shaping the Heart Attack Diagnostics Market?

The heart attack diagnostics market is undergoing a transformative phase, driven by cutting-edge innovations and shifts in clinical practices aimed at improving patient outcomes. One of the most significant developments is the growing adoption of high-sensitivity cardiac troponin (hs-cTn) assays, which can detect extremely low levels of troponin, a key biomarker for myocardial injury. This enhanced sensitivity allows for earlier and more accurate detection of heart attacks, reducing time-to-treatment and improving prognostic accuracy, especially in patients with atypical symptoms. Another major trend is the proliferation of point-of-care testing (POCT) devices, which enable rapid diagnosis at the bedside or even in pre-hospital settings such as ambulances. These portable devices are transforming emergency care by providing results in minutes, thereby supporting quicker triage and reducing reliance on centralized laboratory testing. In addition, the integration of artificial intelligence (AI) and machine learning in diagnostic platforms is revolutionizing the interpretation of complex data, such as ECG patterns and imaging results, leading to earlier detection of subtle signs that might be overlooked by human clinicians. Moreover, multi-marker panels that combine several biomarkers—such as natriuretic peptides and inflammatory markers—are gaining attention, as they offer a more nuanced view of cardiac health and help differentiate heart attacks from other cardiac conditions. Collectively, these trends are making heart attack diagnostics faster, more accurate, and increasingly personalized, reflecting a shift towards precision medicine in cardiovascular care.

How Are New Technologies Redefining Heart Attack Diagnostics?

Technological breakthroughs are reshaping the heart attack diagnostics landscape, making tools more efficient, accessible, and accurate than ever before. One of the most impactful advancements is the miniaturization of diagnostic devices, which has led to the creation of portable and handheld systems that can deliver rapid test results at the patient’s side, even in remote or resource-limited settings. These devices, which include point-of-care cardiac biomarker analyzers and portable ECG monitors, are transforming emergency care by enabling immediate diagnosis and treatment decisions without the need for complex laboratory setups. Wearable technologies are another game-changer in this space, with smartwatches and health bands now equipped to monitor cardiac activity continuously, alerting users and healthcare providers to potential heart attack symptoms in real time. This capability is particularly valuable for high-risk patients, as it allows for proactive management and faster response to potential cardiac events. Additionally, artificial intelligence (AI) is enhancing the capabilities of diagnostic imaging, such as echocardiograms, CT scans, and MRIs, by enabling rapid and more precise interpretation of complex cardiac data. AI-driven platforms can detect subtle patterns and anomalies that might be missed by human eyes, leading to earlier and more confident diagnoses. Furthermore, cloud-based platforms and telehealth integration are enabling remote diagnostics, making it easier for clinicians to access and interpret test results from virtually anywhere. These technological innovations are not only improving the accuracy and accessibility of heart attack diagnostics but are also revolutionizing the way cardiovascular care is delivered, paving the way for a more proactive, data-driven approach to patient management.

What Are the Key Drivers Behind the Rapid Growth of the Heart Attack Diagnostics Market?

The growth in the heart attack diagnostics market is driven by a variety of factors, primarily fueled by advancements in technology, an increasing burden of cardiovascular diseases, and a shift towards rapid and accessible diagnostic solutions. One of the main growth drivers is the global rise in cardiovascular diseases, which remain the leading cause of death worldwide. The aging population, coupled with the increasing prevalence of lifestyle-related risk factors such as obesity, hypertension, and diabetes, is significantly expanding the patient pool in need of reliable diagnostic tools. Moreover, the heightened awareness of the importance of early detection and prevention is boosting demand for advanced biomarker assays and non-invasive imaging technologies that can identify heart attacks in their earliest stages. Another key driver is the growing adoption of point-of-care testing (POCT) devices, which provide rapid diagnostic capabilities in emergency settings, outpatient clinics, and even home care environments. These portable devices are meeting the need for quicker diagnosis and treatment initiation, reducing the strain on hospital laboratories and improving patient throughput in busy emergency departments. Technological innovations, such as AI-enhanced diagnostic platforms and high-sensitivity biomarker tests, are further propelling market growth by offering improved diagnostic accuracy and enabling personalized risk assessment. Additionally, the rising use of telehealth and remote monitoring solutions is expanding the reach of heart attack diagnostics, particularly in rural and underserved areas where access to traditional healthcare facilities is limited. Favorable regulatory frameworks and reimbursement policies are also encouraging the development and adoption of new diagnostic technologies, making them more accessible to a broader patient base. These factors, combined with ongoing investment in research and development, are driving the heart attack diagnostics market forward, establishing it as a key component in the evolving landscape of cardiovascular care.

Select Competitors (Total 35 Featured) -

  • Abbott Laboratories, Inc.
  • ACS Diagnostics
  • Baxter International, Inc.
  • Beckman Coulter, Inc.
  • Canon Medical Systems USA, Inc.
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • HeartBeam
  • Midmark Corporation
  • Philips Healthcare

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Heart Attack Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cardiovascular Diseases Drives Demand for Heart Attack Diagnostic Solutions
    • Here's the Story: How Growing Awareness of Early Detection Expands the Addressable Market for Heart Attack Diagnostics
    • Increasing Adoption of Point-of-Care Testing Propels Market Growth for Rapid Diagnostic Tools
    • Advancements in Biomarker Identification Strengthen Business Case for High-Sensitivity Cardiac Tests
    • Here's How the Shift Towards Personalized Medicine Generates Opportunities for Advanced Cardiac Diagnostic Platforms
    • Rising Focus on Minimally Invasive Testing Boosts Market Potential for Non-Invasive Imaging Technologies
    • Expansion of Telemedicine and Remote Monitoring Transforms Market Dynamics for Heart Attack Diagnostics
    • Emphasis on Reducing Diagnosis Time in Emergency Settings Sustains Demand for Quick and Accurate Testing Methods
    • Here's How Growing Investments in AI and Machine Learning Drive Innovation in Predictive Cardiac Diagnostic Tools
    • Increasing Use of Wearable Health Devices Enhances Market Scope for Continuous Heart Health Monitoring
    • Emergence of At-Home Testing Kits Unlocks New Market Potential in Consumer-Driven Cardiac Health Management
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Heart Attack Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Heart Attack Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Heart Attack Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Heart Attack Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: USA 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 20: Canada Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Canada Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: Canada 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 23: Japan Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Japan Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Japan 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 26: China Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: China Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: China 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Heart Attack Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Heart Attack Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Heart Attack Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Europe 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 35: France Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: France Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: France 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 38: Germany Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Germany Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Germany 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 41: Italy Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Italy Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Italy 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 44: UK Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: UK Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: UK 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 47: Spain Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Spain Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Spain 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 50: Russia Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Russia Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Russia 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 53: Rest of Europe Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Rest of Europe Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Rest of Europe 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Heart Attack Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Heart Attack Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Heart Attack Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Asia-Pacific Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Asia-Pacific 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 62: Australia Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Australia Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Australia 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 65: India Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: India Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: India 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 68: South Korea Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: South Korea Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: South Korea 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 71: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Rest of Asia-Pacific Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Rest of Asia-Pacific 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Heart Attack Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Heart Attack Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Heart Attack Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 77: Latin America Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Latin America Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Latin America 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 80: Argentina Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Argentina Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Argentina 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 83: Brazil Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Brazil Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Brazil 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 86: Mexico Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Mexico Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Mexico 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 89: Rest of Latin America Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Latin America Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Latin America 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Heart Attack Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Heart Attack Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Heart Attack Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 95: Middle East Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Middle East Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Middle East 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 98: Iran Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Iran Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Iran 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 101: Israel Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Israel Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Israel 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 104: Saudi Arabia Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Saudi Arabia Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Saudi Arabia 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 107: UAE Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UAE Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: UAE 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 110: Rest of Middle East Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Rest of Middle East Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Rest of Middle East 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 113: Africa Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Africa Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Africa 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION